Axsome Therapeutics AXSM Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's earnings yield?
- Axsome Therapeutics (AXSM) reported earnings yield of -2.2% in Q1 2026.
- How has Axsome Therapeutics's earnings yield changed year-over-year?
- Axsome Therapeutics's earnings yield increased by 55.5% year-over-year, from -4.9% to -2.2%.
- What is the long-term trend for Axsome Therapeutics's earnings yield?
- Over 5 years (2020 to 2025), Axsome Therapeutics's earnings yield has grown at a -10.0% compound annual growth rate (CAGR), from -3.4% to -2%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.